Buyouts Insider reports that SEC examiners are asking about private funds by name as scrutiny of valuations rises. Suppose a GP client needs an independent valuation-process review before an exam, where can your practice credibly enter?
Buyouts Insider’s “SEC zeroes in on private funds valuations” surfaced the immediate need for defensible valuation processes. Private Funds CFO’s “In the Loop: Value, price and free advice” reinforces the regulatory focus on valuation weaknesses.
Who you will face today
- Your GP clients
Carrying: SEC scrutiny of private-fund valuations is increasing, with Buyouts Insider reporting examiners are asking about funds by name
Ask: Suppose an examiner requests the valuation file for a challenged portfolio company, which part of the process would benefit from an independent review? - Your Operating Partner clients
Carrying: ACG Insights’ Business Services Report 2026 identifies AI as a force reshaping both business operations and M&A
Ask: Suppose AI readiness becomes an investment-committee diligence gate, where is the operating leadership bench too thin to support the work? - Your Portfolio CEO clients
Carrying: PE Hub reports that Battery Ventures backed Vetspire to accelerate AI development for veterinary teams of every size
Ask: Suppose the board asks for an AI operating plan this quarter, who is the named executive owner of the workflow changes needed to make it real?
Signal/Noise Ratio: 53/100 · Mixed Signal